Edita Navratilova

Title: Edita Navratilova: Innovator in Pain-Related Sleep Disorder Treatments

Introduction

Edita Navratilova is a prominent inventor based in Tucson, AZ (US). She has made significant contributions to the field of pain management and sleep disorders. Her innovative work focuses on the intersection of chronic pain and sleep disturbances, which are often interlinked.

Latest Patents

Navratilova holds a patent for "Kappa opioid receptor antagonists for treating pain-related sleep disorders." This invention addresses the common issue faced by chronic pain patients, who frequently experience sleep disturbances. The patent outlines a method for treating these disorders through the administration of a therapeutic amount of a Kappa opioid receptor (KOR) antagonist. This approach aims to break the vicious cycle of pain and sleep loss, providing a novel therapeutic option for improving sleep in chronic pain patients. Furthermore, KOR antagonists may also benefit individuals suffering from other conditions, such as depression or general anxiety disorder, where KOR signaling is involved.

Career Highlights

Navratilova is affiliated with the University of Arizona, where she continues her research and development in this critical area of health. Her work has the potential to transform the treatment landscape for patients dealing with chronic pain and associated sleep issues.

Collaborations

She collaborates with esteemed colleagues, including Frank Porreca and Hisakatsu Ito, who contribute to her research endeavors and enhance the impact of her work.

Conclusion

Edita Navratilova's innovative contributions to the treatment of pain-related sleep disorders highlight her role as a leading inventor in the field. Her patent for KOR antagonists represents a significant advancement in addressing the complex relationship between chronic pain and sleep disturbances.